The National Institutes of Health has reportedly stopped payments of a 9.3 million grant to Emory University as it is investigating an allegation that psychiatrist Charles Nemeroff, a prominent faculty member of the university, did not disclose his consulting properly to the school as required by the federal government.

News media has reported that Nemeroff failed to disclose income of one million dollars from drug companies like GlaxoSmithKline PLC in last few years while heading a research project sponsored by the government studying Glaxo drugs.  

Sen. Charles Grassley is inquiring about the potential conflict of interest.   Emory suspected that there was something going on with the professor, but did not do much to influence Dr. Nemeroff probably because this professor has gotten drug makers to invest heavily in his department.

Emory was said to work with the NIH to assure the government that the university is working its way to comply with the federal rules.   But right now, the NIH placed special requirements on Emory asking the university to provide an assurance of compliance for each NIH grant.